tumor necrosis factor

Type: Keyphrase
Name: tumor necrosis factor
First reported Jul 28 2014 - Updated 13 hours ago - 1 reports

Anti-inflammatory drug could fight Parkinson's

After a study using an anti-inflammatory drug on a Parkinson's model worked well, reers believe it could be of benefit to humans with the condition.Scientists from Emory University School of Medicine in Atlanta, Georgia discovered that the drug XPro1595 ... [Published Noodls - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

CHMP issues positive opinion for Roche RA drug label expansion

07:44 ET | About: Roche Holding Ltd ADR (RHHBY)The EMA's Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion supporting the approval of Roche's (OTCQX:RHHBY) RoActemra/Actemra (tocilizumab) as as treatment for patients with ... [Published Seeking Alpha - Jul 28 2014]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Anti-Inflammatory Drug Reduces Parkinson's Neuronal Loss, Motor Deficits In Animals

The role of inflammation on the development of neurodegeneration that results in Parkinson’s disease has been studied more often over the past few years. And researchers are now trying to use target inflammation for developing Parkinson's treatments. ... [Published Medical Daily - Jul 26 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

EU's CHMP Endorses New Indications for 2 Arthritis Drugs

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has endorsed new indications for tocilizumab ( RoActemra , Roche) and adalimumab ( Humira , AbbVie).On July 24, the CHMP recommended tocilizumab , in combination with ... [Published Diabetes Care - Jul 25 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

How to treat RA in an HIV-positive patient

Dear Dr. Roach: I am 49 years old and fairly healthy. I’ve been HIV-positive for over 20 years and have diabetes. My HIV doctor told me that my rheumatoid factor was 112, and said to see a rheumatologist. He told me that the shot for arthritis isn’t good ... [Published Detroit News - Jul 24 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Method and composition for treatment of renal failure with antibodies and their equivalents as partial or complete replacement for dialysis

A method for treating renal failure associated with advanced stage renal disease includes administering a soluble cytokine receptor to one or more of tumor necrosis factor alpha, interferon gamma or interleukin 6; or antibodies to one or more of interleukin ... [Published Free Patents Online - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Compositions and methods for treatment of angiogenesis in pathological lesions

Treatment of lesions of pathological angiogenesis, especially tumors, rheumatoid arthritis, diabetic retinopathy, age-related muscular degeneration, and angiomas. A conjugate is used comprising a molecule that exerts a biocidal or cytotoxic effect on ... [Published Free Patents Online - Jul 22 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Melanoma associated with tumour necrosis factor-$$ inhibitors: a Research on Adverse Drug events And Reports (RADAR) project.

Melanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project. Br J Dermatol.2014;170(5):1170-2  (ISSN: 1365-2133)Nardone B; Hammel JA; Raisch DW; Weaver LL; Schneider D; West DPBACKGROU ... [Published British Journal of Dermatology - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Study finds common Arthritis drug may slow Alzheimer's

A drug commonly used to treat arthritis could potentially slow the progress of Alzheimer's disease, a study has found. Scientists at the University of Southampton conducted a small control study with a group of 41 patients exhibiting mild or moderate ... [Published Irish Independent - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using assays ... [Published Free Patents Online - Jul 15 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 2 reports

TNF antagonists not linked with cancer in Danish study

The use of tumour necrosis factor alpha (TNF-α) antagonists to treat inflammatory bowel disease (IBD) is not associated with an increased risk of cancer, analysis of a Danish registry indicates1.The analysis, conducted by researchers from State...Related ... [Published BioPortfolio - Jul 09 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

Tumor necrosis factor inhibitors

The present invention is directed to compounds that are allosteric inhibitors of tumor necrosis factor receptor I, compositions comprising such compounds, and methods of using such compounds and compositions thereof in the treatment of TNF-α mediated ... [Published Free Patents Online - Jul 01 2014]

Quotes

Assuming this is true - and that inflammation is wreaking havoc as well - then Dr Tansey believes "we might be able to slow or halt the progression of Parkinson's with a treatment like XPro1595"
"This is an important step forward for anti-inflammatory therapies for Parkinson's disease" said Dr. Malu Tansey, associate professorprofessor of physiology at Emory University School of Medicine, in a press release...
"We are proud to have supported this work and glad to see positive pre-clinical results" said Marco Baptista, PhD, MJFF associate director of research programs...
"The probiotic strains reduced hepatic steatosis in part by lowering serum lipopolysaccharide, and had an anti-inflammatory effect in obese Zucker rats"  the researchers wrote

More Content

All (164) | News (140) | Reports (0) | Blogs (20) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
A20 controls antitumor activity of CD8 T cells ... [Published PNAS - 6 hours ago]
A New Test for Juvenile Idiopathic Arthritis [Published General Medicine eJournal - 13 hours ago]
Anti-inflammatory drug stops Parkinson's neuron... [Published Fierce Biotech Research - 13 hours ago]
Anti-inflammatory drug could fight Parkinson's [Published Noodls - Jul 28 2014]
CHMP issues positive opinion for Roche RA drug ... [Published Seeking Alpha - Jul 28 2014]
Anti-inflammatory activity of extracts of Bushe... [Published BMC - Jul 28 2014]
Anti-Inflammatory Drug Reduces Parkinson's Neur... [Published Medical Daily - Jul 26 2014]
Doctor Criticized For His Questionable 'Treatme... [Published Techdirt - Jul 26 2014]
Simple Growing Pains or Something More? [Published Newswise - Jul 25 2014]
Silencer of Death Domains Controls Cell Death t... [Published Plosone.org - Jul 25 2014]
EU's CHMP Endorses New Indications for 2 Arthri... [Published Diabetes Care - Jul 25 2014]
Anti-inflammatory drug can prevent neuron loss ... [Published EurekAlert! - Jul 25 2014]
The Role of the Circadian Clock in Rheumatoid A... [Published General Medicine eJournal - Jul 25 2014]
Targeting residual risk: a new approach to trea... [Published British Journal of Cardiology - Jul 25 2014]
Probiotics linked to liver fat reduction in rat... [Published Nutra Ingredients USA - Jul 24 2014]
Coming Soon: North American Guidelines for AS a... [Published Consultant Live - Jul 24 2014]
Natural Acne Treatment Balm For Adults And Teen... [Published NBC WAGT 26 - Jul 24 2014]
Effects of dietary omega-3 polyunsaturated fatt... [Published 7thSpace - Jul 24 2014]
How to treat RA in an HIV-positive patient [Published Detroit News - Jul 24 2014]
ELI LILLY : Patent Issued for Enzymes for Reduc... [Published 4 Traders - Jul 24 2014]
Patent Issued for Method of Using Beta-Hydroxy-... [Published 4 Traders - Jul 24 2014]
VERTEX PHARMACEUTICALS : Patent Issued for Proc... [Published 4 Traders - Jul 24 2014]
Researchers at Xiamen University Target Stroke ... [Published HispanicBusiness.com - Jul 23 2014]
Dr. Roach: How to treat arthritis in HIV-positi... [Published Lubbock Online - Jul 23 2014]
Patent Issued for Substances, Compositions and ... [Published 4 Traders - Jul 23 2014]
Breast Cancer–Related Benefits of Weight Loss [Published The ASCO Post - Jul 23 2014]
Legal thuggery directed at Steve Novella and Sc... [Published ScienceBlogs : Combined Feed - Jul 23 2014]
Another Lawsuit To Suppress Legitimate Criticis... [Published NeuroLogica Blog - Jul 23 2014]
Another Lawsuit To Suppress Legitimate Criticis... [Published Science-Based Medicine - Jul 23 2014]
Rcor2 underexpression in senescent mice: a targ... [Published 7thSpace - Jul 23 2014]
1 2 3 4 5 6
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Doctor Criticized For His Questionable 'Treatme... [Published Techdirt - Jul 26 2014]
Dr. Edward Tobinick was the subject of an LA Times article in 2013 -- I'd link to it, but it appears to have disappeared, though I don't know why -- which highlighted his (apparently now discontinued) practice of prescribing a particular drug, Enbrel, ...
Legal thuggery directed at Steve Novella and Sc... [Published ScienceBlogs : Combined Feed - Jul 23 2014]
If there’s one characteristic of supporters of dubious medicine, it’s that they hate criticism. Whereas your average skeptic might not like criticism—sensitivity to criticism being a human trait and all—science- and evidence-based criticism tends to ...
Another Lawsuit To Suppress Legitimate Criticis... [Published NeuroLogica Blog - Jul 23 2014]
I suppose it was inevitable. In fact, I’m a bit surprised it took this long. SGU Productions, the Society for Science-based medicine, and I are being sued for an article that I wrote in May of 2013 on Science-Based Medicine . My SBM piece, which was ...
Another Lawsuit To Suppress Legitimate Criticis... [Published Science-Based Medicine - Jul 23 2014]
I suppose it was inevitable. In fact, I’m a bit surprised it took this long. SGU Productions, the Society for Science-based medicine, and I are being sued for an article that I wrote in May of 2013 on Science-Based Medicine . My SBM piece, which was ...
Do DMTs delay the onset of secondary progressiv... [Published Multiple Sclerosis Research - Jun 27 2014]
How do we define secondary progressive MS? Is it a rational therapeutic target? #MSBlog #MSResearch "An interesting debate has started within the UK MSology community. Do DMTs that have been shown to reduce relapses, relapse associated disability progression, ...
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.